DrugInformations.org

Wyeth Pharmaceuticals, 3rd July, announced that it has received EMEA marketing approval for Relistor? (methylnaltrexone bromide) subcutaneous injection. This first-in-class treatment is indicated for opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to the usual laxative therapy has not been sufficient.

More: continued here

No Comments »

At the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology’s 2008 International Symposium on Supportive Care in Cancer (MASCC / ISOO) held last week in Houston, Texas, The GI Company reported secondary endpoints relating to Oral Mucositis A

More: continued here

No Comments »

To survive tough times, cells sometimes resort to a form of self-cannibalism called autophagy. But as Hashimoto et al. reveal, autophagy can have a down side, destroying the pancreas by prematurely activating a digestive enzyme. In autophagy, a vesicle swallows a portion of cytoplasm and ferries it to the lysosome for digestion. The process is often beneficial, allowing hungry cells to recycle molecules, for example.

More: continued here

No Comments »

“The recent signing of a license agreement between the CSIRO/Australian Capital Ventures Limited joint venture and Austgrains Pty Ltd has paved the way for large scale commercial crops of BARLEYmax®- unique grain developed by CSIRO using conventional plant breeding techniques,” says the Director of the CSIRO Food Futures Flagship, Dr Bruce Lee.

More: continued here

No Comments »

The Foundation for Digestive Health and Nutrition has announced the 2008 American Gastroenterological Association (AGA) Foundation Student Research Fellowship Awards. The Student Research Fellowship Awards program was created by the AGA more than a decade ago to stimulate interest in gastroenterological (GI) research careers in high school, college and medical school students.

More: continued here

No Comments »

Tranzyme Pharma announces the successful results from a “Thorough QT/QTc” study of the company’s lead product TZP-101, an intravenous gastrointestinal prokinetic agent currently in two Phase IIb trials for the treatment of postoperative ileus (POI) and severe gastroparesis.

More: continued here

No Comments »

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, announced it has initiated a clinical study for Colon CAD, its virtual colonoscopy CAD product, in partnership with ACR Image Metrix, a subsidiary of the American College of Radiology (ACR).

More: continued here

No Comments »

Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (Amex: MGT) (the “Company”), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software, today announces the signing of an exclusive CAD clinical research agreement with leading US CT Colonography radiologists, Dr. Perry Pickhardt and Dr. David Kim, from the University of Wisconsin Medical School, Madison, WI. Dr. Pickhardt, Associate Professor of Radiology and Dr.

More: continued here

No Comments »

UT Southwestern Medical Center surgeons have completed the first single-incision Lap-Band weight-loss surgery in Texas.Rather than the traditional five small incisions used for traditional laparoscopic gastric banding surgery, surgeons used a single 8-centimeter incision, reducing future scarring and accelerating healing.”There’s a current revolution in minimally invasive surgery: Can we make laparoscopic surgery better by decreasing the number of incisions?” said Dr.

More: continued here

No Comments »

People with irritable bowel syndrome have a higher than usual number of chilli pepper pain receptors, according to a new study published 11 June.The research, published in the journal Gut, could lead to new therapies for the estimated one in five UK adults who have irritable bowel syndrome (IBS), a painful condition which is poorly understood. Symptoms of IBS include abdominal pain, bloating, and bowel problems such as constipation or diarrhoea.

More: continued here

No Comments »